Altered essential fatty acid metabolism and composition in rat liver, plasma, heart and brain after microalgal DHA addition to the diet.
To investigate the effect of docosahexaenoic acid (DHA) without other highly unsaturated fatty acids (HUFA) on n-3 and n-6 essential fatty acid (EFA) metabolism and fatty acid composition in mammals, a stable isotope tracer technique was used in adult rats fed diets with or without 1.3% of algal DHA in a base diet containing 15% of linoleic acid and 3% of alpha-linolenic acid over 8 weeks. The rats were administered orally a mixed oil containing 48 mg/kg body weight of deuterated linoleic and alpha-linolenic acids and euthanized at 4, 8, 24, 96, 168, 240, 360 and 600 h after administration of the isotopes. Fatty acid compositions and the concentrations of deuterated precursors and their respective metabolites were determined in rat liver, plasma, heart and brain as a function of time. DHA, docosapentaenoic acid and eicosapentaenoic acid in the n-3 EFA family were significantly increased in all organs tested in the DHA-fed group, ranging from 5% to 200% greater in comparison with the control group. The accumulation of the metabolites, deuterated-DHA and deuterated-docosapentaenoic acid n-6 was greatly decreased by 1.5- to 2.5-fold in the dietary DHA group. In summary, feeding preformed DHA led to a marked increase in n-3 HUFA content of rat organs at the expense of n-6 HUFA and also prevented the accumulation of newly synthesized deuterated end products. This is the first study which has isolated the effects of DHA on the de novo metabolism on both the n-6 and n-3 EFA pathways.
Section of Nutritional Neuroscience, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism,National Institutes of Health, Bethesda, MD, USA.
Yu Hong
YH
Lin
Samit
S
Shah
Norman
N
Salem
D000818:Animals; D001921:Brain / Q000187:drug effects*; D004032:Diet; D004042:Dietary Fats, Unsaturated / Q000008:administration & dosage; D004281:Docosahexaenoic Acids / Q000008:administration & dosage*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage; D005228:Fatty Acids, Essential / Q000097:blood* / Q000378:metabolism; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage; D005260:Female; D006321:Heart / Q000187:drug effects*; D019787:Linoleic Acid / Q000008:administration & dosage; D050356:Lipid Metabolism; D008099:Liver / Q000187:drug effects*; D008297:Male; D058086:Microalgae / Q000378:metabolism*; D051381:Rats; D020318:Rats, Long-Evans; D017962:alpha-Linolenic Acid / Q000008:administration & dosage
D004042:Dietary Fats, Unsaturated; D005228:Fatty Acids, Essential; D005231:Fatty Acids, Unsaturated; D017962:alpha-Linolenic Acid; D004281:Docosahexaenoic Acids; D019787:Linoleic Acid; D015118:Eicosapentaenoic Acid; C026219:docosapentaenoic acid